## MCK: McKesson Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($776.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of McKesson Corporation (NYSE:MCK)**
- Source: MarketBeat | 20251218T011249 | Bullish | Relevance: 100%
- Representative Gilbert Ray Cisneros, Jr. recently purchased between $1,001 and $15,000 worth of McKesson Corporation (NYSE:MCK) shares on November 18th, as disclosed on December 15th. McKesson reported strong Q3 earnings, exceeding EPS estimates and showing a 10.2% increase in revenue year-over-year, alongside announcing a quarterly dividend of $0.82 per share. The stock currently trades around $806.86, and analysts maintain a "Moderate Buy" consensus with an average target price of $892.86.

**2. Fortune 50 company sells shuttered Rock Hill facility for $26.5M**
- Source: The Business Journals | 20251217T195001 | Neutral | Relevance: 100%
- McKesson Medical-Surgical Inc. has sold its former Rock Hill facility for $26.5 million to an Atlanta-based investor. The medical supplies distributor had previously closed this warehouse earlier in the year, resulting in layoffs for nearly 180 workers. The report indicates a significant transaction involving a Fortune 50 company's divested asset.

**3. Sanders Morris Harris LLC Makes New Investment in McKesson Corporation $MCK**
- Source: MarketBeat | 20251217T122211 | Bullish | Relevance: 100%
- Sanders Morris Harris LLC has made a new investment in McKesson Corporation, acquiring 3,370 shares valued at approximately $2.603 million in the third quarter. This move is part of a broader trend, with several major institutions increasing their stakes in McKesson, indicating strong institutional confidence in the company, which now owns about 85.07% of the stock. McKesson recently reported strong financial results, including an EPS beat, 10.2% revenue growth, and announced a quarterly dividend, supported by positive analyst ratings and a "Moderate Buy" consensus.

**4. Oak Thistle LLC Acquires Shares of 2,890 McKesson Corporation $MCK**
- Source: MarketBeat | 20251217T120629 | Somewhat-Bullish | Relevance: 100%
- Oak Thistle LLC recently acquired 2,890 shares of McKesson Corporation (NYSE:MCK) in Q3, valued at approximately $2.23 million, contributing to institutional investors owning 85.07% of the company. McKesson reported strong Q3 earnings, beating EPS estimates, and declared a quarterly dividend of $0.82. Analysts maintain a "Moderate Buy" rating with an average price target of $892.86.

**5. McKesson Corporation $MCK Stock Position Decreased by Texas Permanent School Fund Corp**
- Source: MarketBeat | 20251217T110324 | Somewhat-Bullish | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in McKesson Corporation, selling over 10,000 shares to bring its total holdings to 8,780 shares valued at $6.43 million, representing a 54% decrease. Despite this, other institutional investors slightly increased their holdings, and the company recently announced a quarterly dividend of $0.82 per share. McKesson has a "Moderate Buy" consensus rating from analysts with an average price target of $892.86.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $960 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.3%)
- Blackrock Inc.: 9.2% (+0.4%)
- State Street Corpora: 4.7% (+0.9%)
- JPMORGAN CHASE & CO: 4.5% (+16.0%)
- Massachusetts Financ: 3.2% (-1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.98 indicates undervaluation relative to growth. Balance sheet: $2.3B free cash flow. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $100.8B |
| Beta | 0.38 |
| 52W Range | $565.75 - $895.58 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.98 |
| Forward P/E | 18.5 |
| Current P/E | 21.0 |
| YoY Growth | 13.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 1.4% (minimal 5-day change). Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_10 - short-term weakness emerging. Long-term uptrend intact (above SMA200 at 1.11x) but short-term weakness (below SMA20). MACD histogram bearish (-3.52), momentum weakening. RSI neutral at 45. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.39% (CS: 56) | Neutral |
| RSI_14 | 44.8 | Neutral |
| MACD Histogram | -3.52 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.985x | Below |
| vs SMA200 | 1.108x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $810.41
- **Stop Loss:** $776.05 (4.2% risk)
- **Target:** $844.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 27
- **Position Value:** $21,881.07
- **Portfolio %:** 21.88%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $9.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.05 | $9.86 | +8.9% |
| 2025Q2 | $8.15 | $8.26 | +1.4% |
| 2025Q1 | $9.83 | $10.12 | +3.0% |
| 2024Q4 | $7.99 | $8.03 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*